Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.
Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...
MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses t…
Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...
protothema.gr2d
The new drugs coming in 2025 for obesity, alzheimer’s, cancer, and chronic pain
The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...
Jim Cramer Says Eli Lilly and Company (LLY)’s ‘Going To Win’
We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going ...
24/7 Wall St1d
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Yahoo Finance5d
Eli Lilly and Company (LLY)
Two companies with GLP-1 weight loss drugs that might be buying opportunities ... "And then mid-year for Lilly, we have Orforglipron, which is their small molecule pill GLP-1, which could really open ...
israelnewsonline4d
Eli Lilly is looking to extend its winning streak in the broad market to six years
Eli Lilly has surpassed that S&P 500 five years in a row when Wall Street recognized its enormous opportunity in obesity ...
Tesla's Musk Uses Weight-Loss Drugs as Eli Lilly and Novo Nordisk Dominate the Market
Musk revealed using Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, highlighting their popularity for weight management.
Lilly and Novo Went Head-to-Head Over Weight-Loss Drugs in 2024. There’s a Clear Winner.
It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.